Eric A. Hughes, M.D., Ph.D.
Board Member
Monte Rosa Therapeutics, Inc. (GLUE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric A. Hughes, M.D., Ph.D.
Eric A. Hughes, M.D., Ph.D. is recorded as Board Member at Monte Rosa Therapeutics, Inc. (GLUE). Monte Rosa Therapeutics, Inc. reported in an 8-K filed December 13, 2024 that Eric A. Hughes, M.D., Ph.D. was appointed Class III director, effective December 11, 2024.
“On December 11, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Monte Rosa Therapeutics, Inc. (the "Company"), the Board appointed Eric A. Hughes, M.D., Ph.D. to join the Board, effective as of December 11, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-12-11–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Monte Rosa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Ajim Tamboli CFO
- Jennifer Champoux COO
- Sharon Townson CTO
- Philip Nickson General Counsel
- Matthew Bowen Chief Accounting Officer
- Andrew Schiff Board Member
- Anthony M. Manning, Ph.D. Board Member
- Anthony Manning Board Member
- Chandra P. Leo Board Member
- Jan Skvarka, Ph.D., MBA Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.